2,3,4,6-TETRA-O-PIVALOYL-ALPHA-D-GLUCOPYRANOSYL BROMIDE CAS NO.81058-27-7
| Nomen | 2,3,4,6-TETRA-O-PIVALOYL-ALPHA-D-GLUCOPYRANOSYL BROMIDE | ||
| CAS NO. | 81058-27-7 | ||
| Formulae hypotheticae | C26H43BrO9 | M. Pondus | 579.53 |
| MDL No. | MCD08275217 | EINECS | 686-241-8 |
| MP | 147-148°C | BP | 530.5±50.0 °C (Predicta) |
| Densitas | 1.22±0.1 g/cm3(Predicta) | Index refractivus | NA |
| FP | NA | Repono conditione | Inertia atmosphaera, 2-8 ° C * |
| Aspectus | White ad Off-White solidum | ||
| Puritas | 98% | ||
| Applicationem | Intermedia Canagliflozin, ad praeparandum canagliflozin adhiberi potest.Canagliflozin medicamentum inhibitor FDA probatus GLT2 primus est, qui sanguinem saccharo demittere potest frangendo glucosam et per renes excernendo, et in adultis diabetis speciebus tractandis adhibetur. | ||
| Facultates copia | 2,3,4,6-TETRA-O-PIVALOYL-ALPHA-D-GLUCOPYRANOSYL BROMIDE CAS NO.81058-27-7 productio nostra regulariter est, sive parva sample sive magna oneraria plus quam tonagium, societas nostra eget. potest supplere formaliter | ||
| Si interest in 2,3,4,6-TETRA-O-PIVALOYL-ALPHA-D-GLUCOPYRANOSYL BROMIDE CAS NO.81058-27-7, libenter nos tange, quaeso, et optimam qualitatem productorum tibi praestabimus; rationabili pretio et optimo servitio, exspectans cooperationem nostram. | |
| | |
| Phone No. | +86 139 6251 3054 +86 136 2174 3828 |
Producta, quae a consortio recensentur, patentes implicant, quae tantum ad investigationes et progressus et non venales sunt;fructus moderati vendentur stricte obsequio cum legibus Sinensium et legibus regionis ubi mercantur, et omnia producta usui humano non apta sunt.Si venditae patentes praeiudicium constituent, omnia pericula ab emptore ferentur.
Epistulam tuam hic scribe et mitte nobis
![2-(4-Fluorophenyl) -5-[(5-iodo-2-methylphenyl)methyl]thiophene CAS NO.898566-17-1](http://cdn.globalso.com/shlzpharma/898566-17-1.jpeg)
